lomefloxacin has been researched along with Pseudomonas Infections in 8 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Pseudomonas Infections: Infections with bacteria of the genus PSEUDOMONAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The experience with lomefloxacin and ofloxacin respectively in the complex therapy of 26 and 40 patients with burns is described." | 9.08 | [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns]. ( Alekseev, AA; Bobrovnikov, AE; Elagina, LV; Grishina, IA; Iakovlev, VP; Izotova, GN; Krutikov, MG, 1998) |
| "Lomefloxacin is a new quinolone compound with a broad antibacterial spectrum and excellent penetration into the aqueous humor by topical application." | 5.29 | Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. ( Hatano, H; Inoue, K; Liping, W; Shia, S, 1993) |
| " This finding may be due to the somewhat lower initial degree of corneal inflammation in this group and suggests that the course of corneal recovery is predominately dependent on the initial degree of infection with both dosage regimens of lomefloxacin capable of eradicating corneal organisms." | 5.29 | Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen. ( Abalain, ML; Colin, J; Jauch, A; Malet, F, 1995) |
| "The experience with lomefloxacin and ofloxacin respectively in the complex therapy of 26 and 40 patients with burns is described." | 5.08 | [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns]. ( Alekseev, AA; Bobrovnikov, AE; Elagina, LV; Grishina, IA; Iakovlev, VP; Izotova, GN; Krutikov, MG, 1998) |
| "In Japan, cystic fibrosis is rare, and this patient is extremely rare because he has grown up to be a 16-year-old." | 1.29 | [A case of cystic fibrosis in a Japanese student]. ( Kitade, M; Moritaka, T; Nakanishi, N; Ueda, N, 1995) |
| "Lomefloxacin is a new quinolone compound with a broad antibacterial spectrum and excellent penetration into the aqueous humor by topical application." | 1.29 | Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. ( Hatano, H; Inoue, K; Liping, W; Shia, S, 1993) |
| " This finding may be due to the somewhat lower initial degree of corneal inflammation in this group and suggests that the course of corneal recovery is predominately dependent on the initial degree of infection with both dosage regimens of lomefloxacin capable of eradicating corneal organisms." | 1.29 | Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen. ( Abalain, ML; Colin, J; Jauch, A; Malet, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi, N | 1 |
| Ueda, N | 1 |
| Kitade, M | 1 |
| Moritaka, T | 1 |
| Hatano, H | 1 |
| Inoue, K | 1 |
| Shia, S | 1 |
| Liping, W | 1 |
| Drusano, GL | 2 |
| Johnson, DE | 1 |
| Rosen, M | 1 |
| Standiford, HC | 1 |
| Spivey, IM | 1 |
| Malet, F | 1 |
| Colin, J | 1 |
| Jauch, A | 2 |
| Abalain, ML | 1 |
| Elena, PP | 1 |
| Krutikov, MG | 1 |
| Alekseev, AA | 1 |
| Bobrovnikov, AE | 1 |
| Grishina, IA | 1 |
| Elagina, LV | 1 |
| Izotova, GN | 1 |
| Iakovlev, VP | 1 |
1 trial available for lomefloxacin and Pseudomonas Infections
| Article | Year |
|---|---|
[Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
Topics: Adolescent; Adult; Anti-Infective Agents; Burns; Drug Resistance, Microbial; Drug Resistance, Multip | 1998 |
7 other studies available for lomefloxacin and Pseudomonas Infections
| Article | Year |
|---|---|
[A case of cystic fibrosis in a Japanese student].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti- | 1995 |
Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits.
Topics: Animals; Anterior Chamber; Anti-Infective Agents; Colony Count, Microbial; Endophthalmitis; Eye Infe | 1993 |
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.
Topics: Animals; Anti-Infective Agents; Drug Administration Schedule; Female; Fluoroquinolones; Microbial Se | 1993 |
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infectio | 1993 |
Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen.
Topics: Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluo | 1995 |
Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; | 1997 |
Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Administrat | 2000 |